San Diego-primarily based Viking Therapeutics marked alone as a significant competitor in the weight loss drug market place in February immediately after revealing promising information from the mid-stage demo of experimental drug VK2735, which suggested it rivaled—and outperformed—Novo and Lilly drugs when offered as a weekly injection As well… Read More